Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Two new Merck news releases were added to the News releases feed: April 30, 2026 announcing Merck's first-quarter 2026 financial results with regulatory milestones, and April 28, 2026 about the Playing with Heart program with baseball clubs to raise LDL-C awareness. The feed also removed two older items dated April 2, 2026—the Phase 2b/3 trial initiation for MK-8748 and the European Commission's decision on a KEYTRUDA-based treatment.
    Difference
    6%
    Check dated 2026-05-03T13:40:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Updated the “News releases” listing by adding newer dated press releases (from April 20–24, 2026) such as the Hart-Scott-Rodino waiting period expiration for acquiring Terns Pharmaceuticals, a Merck–Google Cloud partnership for agentic AI, FDA approval for IDVYNSO, and additional KEYTRUDA-related updates. Removed earlier dated news releases from late March 2026 (including a Merck-to-hold earnings call item and multiple product/trial/data announcements), shifting the visible results from the prior range (1–10 of 1914) to the latest range (1–10 of 1919).
    Difference
    6%
    Check dated 2026-04-26T08:10:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added two new news releases (April 17, 2026: European Commission approves ENFLONSIA; April 13, 2026: Ifinatamab Deruxtecan granted priority U.S. review). Removed older items (March 16, 2026: ACC.26 Cardio-Pulmonary data; February 28, 2026: KEYTRUDA + WELIREG adjuvant RCC data).
    Difference
    6%
    Check dated 2026-04-19T01:29:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new news release on April 7, 2026 announces Merck's tender offer to acquire Terns Pharmaceuticals, Inc. The listing for the February 28, 2026 release about WELIREG+LENVIMA has been removed.
    Difference
    5%
    Check dated 2026-04-11T20:59:19.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added several new news release entries for April and March 2026. Removed older February 2026 items from the News releases listing.
    Difference
    6%
    Check dated 2026-04-04T19:05:10.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Adds a March 25, 2026 press release announcing Merck's acquisition of Terns Pharmaceuticals (TERN-701) to expand its hematology pipeline, and removes the February 23, 2026 press release about evolving the human health operating structure from the listing.
    Difference
    5%
    Check dated 2026-03-28T13:47:22.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.